• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非靶向液相色谱-质谱代谢组学评估 HepaRG®细胞中药物诱导的胆汁淤积特征。

Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG® cells.

机构信息

Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium; Research group In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium.

Department of Mathematics & Computer Science, University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium; Biomedical Informatics Network Antwerpen (Biomina), University of Antwerp, Middelheimlaan 1, 2020 Antwerp, Belgium.

出版信息

Toxicol Appl Pharmacol. 2019 Sep 15;379:114666. doi: 10.1016/j.taap.2019.114666. Epub 2019 Jul 16.

DOI:10.1016/j.taap.2019.114666
PMID:31323262
Abstract

Cholestasis is a liver disease associated with retention of bile in the liver, which leads to local hepatic inflammation and severe liver damage. In order to investigate the mode of action of drug-induced cholestasis, in vitro models have shown to be able to recapitulate important elements of this disease. In this study, we applied untargeted metabolomics to investigate the metabolic perturbances in HepaRG® cells exposed for 24 h and 72 h to bosentan, a cholestatic reference toxicant. Intracellular profiles were extracted and analysed with liquid chromatography and accurate-mass spectrometry. Metabolites of interest were selected using partial least-squares discriminant analysis and random forest classifier models. The observed metabolic patterns associated with cholestasis in vitro were complex. Acute (24 h) exposure revealed metabolites related to apoptosis, such as ceramide and triglyceride accumulation, in combination with phosphatidylethanolamine, choline and carnitine depletion. Metabolomic alterations during exposure to lower dosages and a prolonged exposure (72 h) included carnitine upregulation and changes in the polyamine metabolism. These metabolites were linked to changes in phospholipid metabolism, mitochondrial pathways and energy homeostasis. The metabolic changes confirmed the mitotoxic effects of bosentan and revealed the potential involvement of phospholipid metabolism as part of the mode of action of drug-induced cholestasis.

摘要

胆汁淤积症是一种与胆汁在肝脏中滞留有关的肝脏疾病,可导致局部肝炎症和严重的肝损伤。为了研究药物性胆汁淤积症的作用机制,体外模型已被证明能够重现该疾病的重要元素。在这项研究中,我们应用非靶向代谢组学方法来研究 HepaRG®细胞在暴露于波生坦(一种胆汁淤积的参考毒性物质)24 小时和 72 小时后的代谢紊乱。用液相色谱和精确质量质谱法提取和分析细胞内谱。使用偏最小二乘判别分析和随机森林分类器模型选择感兴趣的代谢物。与体外胆汁淤积相关的观察到的代谢模式是复杂的。急性(24 小时)暴露显示与细胞凋亡相关的代谢物,如神经酰胺和甘油三酯积累,同时伴有磷脂酰乙醇胺、胆碱和肉碱耗竭。在较低剂量和延长暴露(72 小时)期间,代谢组学的改变包括肉碱上调和多胺代谢的改变。这些代谢物与磷脂代谢、线粒体途径和能量稳态的变化有关。这些代谢变化证实了波生坦的线粒体毒性作用,并揭示了磷脂代谢可能是药物性胆汁淤积症作用机制的一部分。

相似文献

1
Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG® cells.非靶向液相色谱-质谱代谢组学评估 HepaRG®细胞中药物诱导的胆汁淤积特征。
Toxicol Appl Pharmacol. 2019 Sep 15;379:114666. doi: 10.1016/j.taap.2019.114666. Epub 2019 Jul 16.
2
Metabolomics profiling of steatosis progression in HepaRG cells using sodium valproate.使用丙戊酸钠对HepaRG细胞中脂肪变性进展进行代谢组学分析。
Toxicol Lett. 2018 Apr;286:22-30. doi: 10.1016/j.toxlet.2017.12.015. Epub 2018 Jan 31.
3
Metabolomic analysis of cholestatic liver damage in mice.对小鼠胆汁淤积性肝损伤的代谢组学分析。
Food Chem Toxicol. 2018 Oct;120:253-260. doi: 10.1016/j.fct.2018.07.022. Epub 2018 Jul 20.
4
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures.基于组学的博森坦诱导人肝癌 HepaRG 细胞培养物的反应。
Arch Toxicol. 2018 Jun;92(6):1939-1952. doi: 10.1007/s00204-018-2214-z. Epub 2018 May 14.
5
Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.HepaRG细胞中BSEP功能的破坏改变胆汁酸代谢,是药物性胆汁淤积损伤的易感因素。
Mol Pharm. 2016 Apr 4;13(4):1206-16. doi: 10.1021/acs.molpharmaceut.5b00659. Epub 2016 Mar 8.
6
Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics.基于液相色谱-质谱联用的非靶向代谢组学分析乙醇诱导的 HepaRG 细胞肝毒性的代谢特征。
J Proteome Res. 2022 Apr 1;21(4):1153-1166. doi: 10.1021/acs.jproteome.2c00029. Epub 2022 Mar 11.
7
UPLC-MS-based metabonomic analysis of intervention effects of Da-Huang-Xiao-Shi decoction on ANIT-induced cholestasis.基于 UPLC-MS 的大黄硝石汤干预对 ANIT 诱导的胆汁淤积症的代谢组学分析。
J Ethnopharmacol. 2019 Jun 28;238:111860. doi: 10.1016/j.jep.2019.111860. Epub 2019 Apr 6.
8
Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures.基于综合蛋白质组学和代谢组学特征探究龙胆苦苷对α-萘异硫氰酸酯诱导的大鼠胆汁淤积性肝损伤的保肝作用
Cell Physiol Biochem. 2018;49(4):1304-1319. doi: 10.1159/000493409. Epub 2018 Sep 17.
9
Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.用于评估药物性胆汁淤积的器官型3D HepaRG肝脏模型
Methods Mol Biol. 2019;1981:313-323. doi: 10.1007/978-1-4939-9420-5_20.
10
From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells.封面文章:利用HepaRG细胞对内皮受体拮抗剂的细胞毒性和胆汁淤积潜力的机制性见解
Toxicol Sci. 2017 Jun 1;157(2):451-464. doi: 10.1093/toxsci/kfx062.

引用本文的文献

1
Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injury.基于细胞的方法用于对药物性胆汁淤积性肝损伤的机制理解
Arch Toxicol. 2025 Mar 11. doi: 10.1007/s00204-025-04016-0.
2
The assessment of the potential hepatotoxicity of new drugs by metabolomics.通过代谢组学评估新药的潜在肝毒性。
Front Pharmacol. 2023 May 5;14:1155271. doi: 10.3389/fphar.2023.1155271. eCollection 2023.
3
In Vitro Models for Studying Chronic Drug-Induced Liver Injury.用于研究慢性药物性肝损伤的体外模型。
Int J Mol Sci. 2022 Sep 28;23(19):11428. doi: 10.3390/ijms231911428.
4
Biomarkers and Mechanism Analysis for Polygoni Multiflori Radix Preparata-Induced Liver Injury by UHPLC-Q-TOF-MS-Based Metabolomics.基于超高效液相色谱-四极杆飞行时间质谱代谢组学的制何首乌致肝损伤生物标志物及机制分析
Evid Based Complement Alternat Med. 2021 Nov 23;2021:7677392. doi: 10.1155/2021/7677392. eCollection 2021.
5
A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.一种基于靶向代谢组学的分析方法,利用人诱导多能干细胞衍生的心肌细胞,鉴定结构和功能的心脏毒性潜力。
Toxicol Sci. 2020 Apr 1;174(2):218-240. doi: 10.1093/toxsci/kfaa015.
6
Exposure of HepaRG Cells to Sodium Saccharin Underpins the Importance of Including Non-Hepatotoxic Compounds When Investigating Toxicological Modes of Action Using Metabolomics.将HepaRG细胞暴露于糖精钠,凸显了在使用代谢组学研究毒理学作用模式时纳入非肝毒性化合物的重要性。
Metabolites. 2019 Nov 4;9(11):265. doi: 10.3390/metabo9110265.